CELCCelcuity Inc.

HealthcareUSD
$95.11

The financials

Celcuity Inc. by the numbers

Celcuity Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$66M−$44Mn/a
Net income−$79M−$45Mn/a
Diluted EPS−$1.44−$1.04n/a

Biotechnology

Ranks #141 of 145 by Smart Score

Compare peers
ERAS-0.66%
Erasca, Inc.
EWTX-1.4%
Edgewise Therapeutics, Inc.
TNGX+3.5%
Tango Therapeutics, Inc.
MANE+1.8%
Veradermics, Incorporated
DNTH+0.85%
Dianthus Therapeutics, Inc.
VKTX-2.3%
Viking Therapeutics, Inc.